13D/13G Filings - MOLECULAR PARTNERS AG (MOLN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2025-05-02
5:14 pm
Purchase		2021-06-1513GMolecular Partners AG
MOLN		SUVRETTA CAPITAL MANAGEMENT LLC4,284,806
10.600%		4,284,806increase
(New Position)		Filing
History
2024-10-29
4:32 pm
Purchase		2024-10-2513DMolecular Partners AG
MOLN		BIOTECHNOLOGY VALUE FUND L P9,888,592
24.500%		1,192,387increase
(+13.71%)		Filing
History
2023-11-20
5:07 pm
Purchase		2023-11-1713DMolecular Partners AG
MOLN		BIOTECHNOLOGY VALUE FUND L P8,696,205
23.900%		2,203,688increase
(+33.94%)		Filing
History
2023-11-07
4:41 pm
Purchase		2023-11-0313GMolecular Partners AG
MOLN		BIOTECHNOLOGY VALUE FUND L P6,492,517
17.900%		1,982,445increase
(+43.96%)		Filing
History
2023-02-14
12:10 pm
Sale		2022-12-3113GMolecular Partners AG
MOLN		BIOTECHNOLOGY VALUE FUND L P4,510,072
12.600%		-16,210decrease
(-0.36%)		Filing
History
2022-01-12
5:05 pm
Purchase		2022-01-1013GMolecular Partners AG
MOLN		BIOTECHNOLOGY VALUE FUND L P4,526,282
14.100%		1,425,000increase
(+45.95%)		Filing
History
2022-01-12
5:03 pm
Purchase		2021-12-3113GMolecular Partners AG
MOLN		BIOTECHNOLOGY VALUE FUND L P3,101,282
9.700%		602,381increase
(+24.11%)		Filing
History
2021-09-15
5:17 pm
Purchase		2021-08-1613GMolecular Partners AG
MOLN		BIOTECHNOLOGY VALUE FUND L P2,498,901
7.700%		2,498,901increase
(New Position)		Filing
History